ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1,2,Tachyphylaxis,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2,2,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
3,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
3,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3,3,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
